Related Experiment Video
Updated: Jun 13, 2025

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
A Case-Based Approach to the Management of Patients with Chronic Coronary Disease: Updates from the 2023 AHA/ACC
Yoo Jin Kim1, Jasmine Malhi1, Jeff Trost2
1Department of Medicine, Johns Hopkins University, Baltimore, MD.
Insights
The 2023 American Heart Association/American College of Cardiology guidelines offer updated chronic coronary disease management strategies. These recommendations cover asymptomatic disease, stable angina, nonobstructive coronary disease, and left ventricular dysfunction.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Guidelines
Background:
- The 2023 American Heart Association (AHA)/American College of Cardiology (ACC) guideline provides crucial updates for managing chronic coronary disease (CCD).
- CCD affects diverse patient populations, necessitating updated clinical guidance.
Purpose of the Study:
- To highlight key recommendations from the 2023 AHA/ACC guideline.
- To illustrate guideline application through hypothetical patient cases.
Main Methods:
- Review of the 2023 AHA/ACC Multisociety Guideline for the Management of Patients with Chronic Coronary Disease.
- Development of four hypothetical cases representing distinct patient profiles.
Main Results:
- The guideline addresses asymptomatic coronary artery disease.
- It provides recommendations for stable angina or equivalent symptoms.
- It includes guidance for symptomatic nonobstructive coronary disease (microvascular dysfunction, vasospasm).
- It covers left ventricular systolic dysfunction in patients with known coronary artery disease.
Conclusions:
- The 2023 guideline offers a comprehensive framework for managing patients with chronic coronary disease.
- Understanding these updates is essential for optimizing patient care across various clinical scenarios.
Abstract:
The 2023 American Heart Association (AHA)/American College of Cardiology (ACC) Multisociety Guideline for the Management of Patients with Chronic Coronary Disease presents important updates to the care of patients with chronic coronary disease. The recommendations of these guidelines inform the care for patients with 1) asymptomatic coronary artery disease, 2) stable angina or equivalent symptoms (e.g., dyspnea upon exertion), 3) symptomatic nonobstructive coronary disease including coronary microvascular dysfunction and vasospasm, and 4) left ventricular (LV) systolic dysfunction with known coronary artery disease. In this review, we aim to demonstrate key recommendations in the 2023 guideline using the following four hypothetical cases.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Pancreatitis II: Collaborative Care
Assessment:
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...

